PBAC approves long-acting injectable PrEP for HIV
Patients with contraindications to daily oral HIV pre-exposure prophylaxis could soon access a PBS-subsidised long-acting injectable. Following its September meeting, the PBAC has recommended a…
Patients with contraindications to daily oral HIV pre-exposure prophylaxis could soon access a PBS-subsidised long-acting injectable. Following its September meeting, the PBAC has recommended a…
Victoria and Tasmania are now the only states where co-payments for HIV antiretrovirals remain after the Queensland Government announced it would waive fees from 1…
Further details about a man who has become possibly the sixth case of a person with HIV to be considered ‘cured’ of the disease are…
The founder of a well-known Canberra general practice originally set up to treat HIV patients says she has tried everything to remain open, but the…
Kwame is a 38-year-old African man who presents with a dry cough and dyspnoea on exertion for 3-4 weeks. Kwame has been on antiretroviral therapy…
The TGA has yet to approve the fluid-based oral testing kits that many patients prefer.
Professor Joel Palefsky has high hopes that screening will prove cost-effective.
The potentially practice-changing study shows treating precursor lesions reduces cancer in people with HIV.
Fewer sexual encounters due to COVID-19 restrictions is a likely driver says the Kirby Institute.
The young Argentinian woman's case offers hope for a sterilising HIV-1 cure, say US doctors.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.